2 completed, 1 terminated, 1 unknown. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Mania: new trials by email Literature Review of Mania trials Research Report on Mania
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Far Infrared Radiation Treatment for Bipolar Condition Far infrared - Bipolar Disorder | Phase 1 | Unknown | GAAD Medical Research Institute Inc. | 3 | 2006-09-01 | 2009-08-17 |
| Open Label Trial of Acamprosate in Bipolar Alcoholics Acamprosate - Alcohol Dependence, Bipolar Disorder | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 9 | 2006-04-01 | 2008-09-19 |
| Taurine in Adolescents With Bipolar Disorder Taurine - Bipolar Disorder | Phase 1 | Terminated | Cambridge Health Alliance | 4 | 2006-02-01 | 2010-02-03 |
| Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents Aripiprazole - Schizophrenia, Mania | Phase 1 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 21 | 2004-07-01 | 2026-06-22 |
Bipolar Disorder (3) · Alcoholism (1) · Behavior, Addictive (1) · Depression (1) · Impulsive Behavior (1) · Schizophrenia (1) · Substance-Related Disorders (1)
Mental Disorders (4) · Nervous System Diseases (4) · Neurobehavioral Manifestations (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Bipolar and Related Disorders (3) · Mood Disorders (3) · Alcohol-Related Disorders (1) · Behavior (1) · Behavioral Symptoms (1) · Chemically-Induced Disorders (1) · Compulsive Behavior (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Acamprosate (1) · Aripiprazole (1) · Taurine (1)
Cambridge Health Alliance (1) · GAAD Medical Research Institute Inc. (1) · Medical University of South Carolina (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
United States (2) · Canada (1)
Bryan K. Tolliver, M.D., Ph.D. (1) · Jean Frazier, MD (1) · Kathleen T. Brady, M.D., Ph.D. (1) · Ken Nedd, M.D. (1) · Kwasi Donyina, Ph.D. (1)
K24DA000435 (1)